Keywords:
миома матки, Bcl-2, апоптоз, гормональная регуляция, сигнальные пути.References
Adekunle, A. A., Olayemi, O. O., & Abdullahi, H. S. (2024). Immunohistochemical expression of Bcl-2 in uterine leiomyoma: Correlation with clinicopathologic parameters. Journal of Gynecologic Pathology, 33(2), 45-52.
Alghamdi A. et al. Correlation between Bcl-2 and tumor size in uterine fibroids. Int J Gynecol Pathol. 2020; 39(3):259-266.
Arip M. et al. miR-16 regulates apoptosis via Bcl-2 in uterine fibroids. Mol Med Rep. 2022; 25(3):147.
Bulun S. E. Uterine fibroids: cellular mechanisms and treatment targets. Nat Rev Endocrinol. 2023; 19:145-160.
Chen J. Bcl-2 family and apoptosis regulation in uterine disorders. Cell Mol Life Sci. 2025; 82(4):1193-1207.
Huang H. F., Zheng J. H., Chen M. Apoptosis-related genes in uterine leiomyoma. Hum Reprod. 2002; 17(11):2864-2871.
Irnazarova D.Kh. et al. Clinical and Morphological Features of Uterine Fibroid. Central Asian Journal of Medical and Natural Science 4 (6), 1435-1441, https://doi.org/10.51699/cajmns.v4i6.2249
Machado-Lopez, A.; Simón, C.; Mas, A. Molecular and Cellular Insights into the Development of Uterine Fibroids. Int. J. Mol. Sci. 2021, 22, 8483. https://doi.org/10.3390/ ijms22168483
Matsuo H., Maruo T., Samoto T. Role of Bcl-2 protein in uterine leiomyoma growth. J Clin Endocrinol Metab. 1997; 82(2):293-299.
Pekonen F. et al. Expression of Bcl-2 proto-oncogene in human uterine leiomyoma and myometrium. Obstet Gynecol. 1998; 91(2):213-219.
Pfaff, M., Lee, S. Y., & Kim, H. J. (2025). Decoding the epigenome: Comparative analysis of uterine leiomyoma and normal myometrium. Epigenetics & Chromatin, 18(1), 14. https://doi.org/10.1186/s1 3072-025-00614-1
Qian, S., Xu, L., & Zhou, M. (2022). The role of Bcl-2 family proteins in regulating apoptosis and the development of drugs targeting BCL-2 anti-apoptotic proteins. Frontiers in Oncology, 12, 101–118. https://doi.org/10.3389/fonc.2022.875421
Sato S. et al. Expression of Bcl-2 and Bax in leiomyoma tissues. Gynecol Obstet Invest. 2014; 78(4):256–262.
Stewart E. A. Uterine fibroids: pathogenesis and treatment. N Engl J Med. 2022; 386:1398–1408.
Vafaei, S., Rahmani, H., & Ebrahimi, R. (2023). Natural compounds modulating Bcl-2 /BAX ratio in uterine fibroid therapy: A systematic review. Molecules, 28 (4), 1532. https://doi.org/10.3390/ molecules28041532
Wang H. et al. miRNA-34a suppresses Bcl-2 in uterine leiomyoma cells. J Reprod Med. 2018; 63(6):421–427.
Wu X., Serna V. A., Thomas P. Progesterone receptor regulates Bcl-2 in myometrium. Endocrinology. 2002; 143(3):1102–1110.
Zhu W., Wang X., Xu J. PI3K/AKT signaling mediates Bcl-2 expression in leiomyoma cells. Reprod Sci. 2020; 27(11):2113–2123.